Precautions in the management of opioid agonist therapy: from target population characteristics to new formulations and post-marketing monitoring - a focus on the Italian system
Opioid use disorder (OUD) is a serious medical condition with vast social, health and economic impact. Individuals with OUD are prescribed opioid agonist therapies, such as methadone, levomethadone, buprenorphine or naloxone/buprenorphine, to reduce the risks associated with illegal substance abuse,...
Saved in:
Main Authors: | Guido Mannaioni (Author), Fabio Lugoboni (Author) |
---|---|
Format: | Book |
Published: |
BioExcel Publishing Ltd,
2023-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Corrigendum: Precautions in the management of opioid agonist therapy: from target population characteristics to new formulations and post-marketing monitoring - a focus on the Italian system
by: Guido Mannaioni, et al.
Published: (2023) -
Impact of opioid-induced constipation on opioid substitution therapy management: the patient perspective
by: Fabio Lugoboni, et al.
Published: (2021) -
Opioid Antagonists: Will they Solve all of the Problems Associated with Opioid Agonists?
by: Adam M Kaye
Published: (2014) -
Therapeutic Potential of Kappa Opioid Agonists
by: Tyler C. Beck, et al.
Published: (2019) -
Interim opioid agonist treatment for opioid addiction: a systematic review
by: Laura Samsó Jofra, et al.
Published: (2022)